Cleared Traditional

K170239 - Leica FL560

K170239 is the FDA 510(k) clearance for Leica FL560 by Leica Microsystems (Schweiz) AG. It is a Class 2 Radiology device (product code IZI) cleared through the Traditional 510(k) pathway after a 160-day FDA review.

K170239 · Leica Microsystems (Schweiz) AG · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2017
Decision
160d
Days
Class 2
Risk

K170239 is an FDA 510(k) clearance for the Leica FL560. Classified as System, X-ray, Angiographic (product code IZI), Class II - Special Controls.

Submitted by Leica Microsystems (Schweiz) AG (Heerbrugg, CH). The FDA issued a Cleared decision on July 5, 2017 after a review of 160 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1600 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Leica Microsystems (Schweiz) AG devices

Submission Details

510(k) Number K170239 FDA.gov
FDA Decision Cleared Substantially Equivalent - De Novo Granted (SEKD)
Date Received January 26, 2017
Decision Date July 05, 2017
Days to Decision 160 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
53d slower than avg
Panel avg: 107d · This submission: 160d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IZI System, X-ray, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1600
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IZI System, X-ray, Angiographic

All 98
Devices cleared under the same product code (IZI) and FDA review panel - the closest regulatory comparables to K170239.
GLOW800
K181537 · Leica Microsystems (Schweiz) AG · Sep 2018
CAAS Workstation
K180019 · Pie Medical Imaging BV · May 2018
YELLOW 560 Fluorescence Module
K162991 · Carl Zeiss Meditec, AG · Jul 2017
ALLURA XPER FD OR TABLE SERIES
K130842 · Philips Medical Systems Nederland B.V. · May 2013
GE INNOVA SOLID STATE XRAY IMAGER FLUROSOPIC X RAY SYSTEM
K113034 · Ge Healthcare · Dec 2011
INTEGRATED INNOVA - S5I SYSTEM OPTION
K111209 · Ge Healthcare · Jul 2011